Paper Details

  1. Home
  2. Paper Details

Design and rationale of the ARBITER 6 trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol)-6-HDL and LDL Treatment Strategies in Atherosclerosis (HALTS).

Author: DevinePatrick J, TaylorAllen J, TurcoMark A

Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study explores the potential benefits of targeting very low LDL cholesterol levels (ultra-low) and increasing HDL cholesterol levels to reduce the risk of heart disease. While guidelines acknowledge the importance of high HDL cholesterol, they do not explicitly recommend raising it as a treatment goal. This study discusses the findings of a recent trial that showed raising HDL cholesterol with extended-release niacin, in addition to statins, may be beneficial. The study highlights the need for further research to determine if targeting very low LDL cholesterol levels and increasing HDL cholesterol is a more effective strategy than simply focusing on lowering LDL cholesterol.
Paper Details　
Original Abstract of the Article :
Recent evidence on the use of statin therapy indicates the potential for ultra-low levels of LDL-C to provide greater protection from recurrent coronary heart disease events. Guidelines for the treatment of lipid disorders were revised to indicate that an LDL-C treatment goal of 70 mg/dl was optiona...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s10557-007-6020-8

データ提供：米国国立医学図書館（NLM）

LDL-C and HDL-C: A Balancing Act in Atherosclerosis

The battle against atherosclerosis, a formidable enemy that can lead to heart disease, is a continuous quest. Statins, our trusted allies, have been instrumental in reducing LDL-C, the bad cholesterol. Now, the focus shifts to optimizing HDL-C, the good cholesterol, and exploring its potential for preventing heart disease. This study, like a seasoned caravan leader, delves into the intricacies of LDL-C and HDL-C, comparing different treatment strategies in secondary prevention.

The ARBITER 2 trial demonstrated the potential of raising HDL-C with extended release niacin when combined with statin monotherapy. However, whether this approach is superior to targeting lower LDL-C levels remains unknown. This study, like a meticulous explorer navigating uncharted territory, aims to investigate this question, shedding light on the optimal combination of LDL-C and HDL-C management for improved cardiovascular health.

A New Path in Atherosclerosis Treatment

This research explores a new path in atherosclerosis treatment, highlighting the importance of balancing LDL-C and HDL-C levels for optimal cardiovascular health. The ARBITER 6 trial, like a compass guiding our way, aims to uncover the best combination of LDL-C and HDL-C management strategies for preventing heart disease.

Balancing Act for a Healthy Heart

This research highlights the importance of a balanced approach to managing cholesterol levels. It reminds us that while lowering LDL-C is crucial, optimizing HDL-C may be equally important in preventing heart disease. This study encourages further research into the role of HDL-C in cardiovascular health, paving the way for more effective and personalized treatments.

Dr.Camel's Conclusion

The battle against atherosclerosis is a complex and multifaceted journey. This research, like a wise camel guiding us through the desert of cholesterol, emphasizes the need for a balanced approach that considers both LDL-C and HDL-C. It is a reminder that by understanding the intricate workings of the cardiovascular system, we can make significant strides towards a healthier heart.

Date :
  1. Date Completed 2007-10-30
  2. Date Revised 2016-10-20
Further Info :

Pubmed ID

17404825

DOI: Digital Object Identifier

10.1007/s10557-007-6020-8

Related Literature

Article Analysis
・Effective treatment of cholesterol
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.